Insulet (PODD) Tops Q1 EPS by 17c; Guides
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $149.01 +0.60%
EPS Growth %: +28.2%
Financial Fact:
Net loss: -3.08M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +28.2%
Financial Fact:
Net loss: -3.08M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q1 EPS of $0.40, $0.17 better than the analyst estimate of $0.23. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $288.19 million.
GUIDANCE:
For the year ending December 31, 2022, the Company is reaffirming its expected revenue growth of 12% to 16%.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Infosys Limited (INFY) Reports In-Line Q3 EPS
- JPMorgan Upgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
